Bone marrow concentrate treatment in patients with lower extremity fractures over 65 years of age

Researcher-led exploratory clinical trials to evaluate the safety and effectiveness of bone marrow concentrate and collagen mixed injection to promote bone union on osteoporosis lower extremity fracture patients aged 65 older

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0009676

Enrollment

Registered

2024-08-02

Start date

2023-12-02

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device, Biological/Vaccine, Stem Cell, Procedure/Surgery : 1) Subjects who agreed to the clinical study with osteoporosis lower extremity fractures were randomly (50% probability) assigned to

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients with lower extremity fracture with osteoporosis aged 65 years or older 2) AO Fracture Classification A, B, and C are fractures in which the shape of the fracture is spiral, oblique, transverse, wedge fracture, compound fracture, multiple fracture, fracture site displacement 3) A person who voluntarily agreed to the research, such as research methods and procedures, after receiving a sufficient explanation for the research matters in this clinical study [If it is difficult for the subject to voluntarily consent to the cognitive impairment caused by aging due to the nature of this clinical study, the consent of the legal representative (or agent)] 4) Osteoporosis medication or T-Score -2.5 or less on bone density test (BMD)

Exclusion criteria

Exclusion criteria: 1) a patient with blood cancer, including multiple myeloma 2) a bone tumor patient 3) A person who is being treated for an autoimmune disease such as rheumatoid disease 4) a patient currently being treated for an infectious disease 5) If there is no displacement or fracture of the fracture part as a simple fracture according to the AO fracture classification 6) A person who refuses to participate in this clinical study [If it is difficult for the subject to voluntarily agree or refuse to participate in the study, such as cognitive impairment due to aging, due to the nature of this clinical study, a legal representative (or agent) refuses to participate in the study]

Design outcomes

Primary

Measure	Time frame
Infection status	—

Countries

Korea, Republic of

Contacts

Public ContactKyung Yil Kang

Catholic Kwandong University International St.Mary's Hospital

fbdlxk@naver.com+82-32-290-3158

Outcome results